[Neuroscience and veterinary medicine].

Dtsch Tierarztl Wochenschr

Lehrstuhl für Allgemeine Pathologie und Neuropathologie, Tierärztlichen Fakultät, Universität München.

Published: November 1994

Clinical neurology in veterinary medicine did receive its initial secure basis by Hermann DEXLER in Vienna during late fall of 19th century. He could demonstrate that knowledges in neuroanatomy and -pathology are basis requirements for a reliable interpretation of morbid entities of central and peripheral nervous system. During the following decades a varied development of neurosciences was to be observed in veterinary medicine, comparing different countries. In general, the most important influences--based upon comparative neuromorphology--came from pathologists. Thus, infectious morbid entities, hereditary diseases, malformations, neurodegenerative diseases, neurooncology, and traumatology had become central challenges for neuroscientists. In this context it is no surprise that BSE has brought a tremendous impact on research work in the whole field of human and animal spongiform encephalopathies. Regrettably, the integration of clinical neurology and neuropathology within the teaching programmes of the European veterinary colleges, especially in Germany, has still not reached a satisfactory level. Specific training procedures realized by several schools in USA and UK might serve as sound examples in view of the permanent growing importance of neurological diseases in large and small animal practice.

Download full-text PDF

Source

Publication Analysis

Top Keywords

clinical neurology
8
veterinary medicine
8
morbid entities
8
[neuroscience veterinary
4
veterinary medicine]
4
medicine] clinical
4
neurology veterinary
4
medicine receive
4
receive initial
4
initial secure
4

Similar Publications

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) that is usually diagnosed between the ages of 20 and 40. Changes in the immune system also observed in cancer may suggest a higher prevalence of cancer in the MS patient population. In recent years, many highly effective immunosuppressive drugs have been introduced into disease-modifying therapy (DMT) which may be associated with a higher risk of cancer development in patients with MS.

View Article and Find Full Text PDF

Background: In recent decades, relapsing remitting multiple sclerosis (MS) became more treatable through new disease-modifying therapies (DMTs). Identifying safe treatments with minimal fetal risks for family planning is needed.

Methods: In this prospective cohort from the German MS and Pregnancy Registry (DMSKW), we analyzed pregnancy and neonatal outcomes in MS-patients using descriptive statistics and logistic/linear regression models to compare DMT-exposed pregnancies to DMT-unexposed pregnancies.

View Article and Find Full Text PDF

Introduction: Timely detection and tracking of Alzheimer's disease (AD) -related cognitive decline has become a public health priority. We investigated whether the NIH Toolbox for Assessment of Neurological and Behavioral Function-Cognition Battery (NIHTB-CB) detects AD-related cognitive decline.

Methods:  = 171 participants (age 76.

View Article and Find Full Text PDF

Introduction: Diagnostic performance of optical coherence tomography (OCT) to detect Alzheimer's disease (AD) and mild cognitive impairment (MCI) remains limited. We aimed to develop a deep-learning algorithm using OCT to detect AD and MCI.

Methods: We performed a cross-sectional study involving 228 Asian participants (173 cases/55 controls) for model development and testing on 68 Asian (52 cases/16 controls) and 85 White (39 cases/46 controls) participants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!